ES2078130T3 - Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen. - Google Patents

Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen.

Info

Publication number
ES2078130T3
ES2078130T3 ES94400009T ES94400009T ES2078130T3 ES 2078130 T3 ES2078130 T3 ES 2078130T3 ES 94400009 T ES94400009 T ES 94400009T ES 94400009 T ES94400009 T ES 94400009T ES 2078130 T3 ES2078130 T3 ES 2078130T3
Authority
ES
Spain
Prior art keywords
propenamides
hidroxi
ciano
medicines
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400009T
Other languages
English (en)
Inventor
Elizabeth Anne Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2078130T3 publication Critical patent/ES2078130T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A LOS PRODUCTOS (I), EN LOS QUE A, B Y E REPRESENTAN = CH CICLOALQUILO, ALQUENILO, ALQUINILO (-> C6); R1 REPRESENTA H, ALQUILO (C1 CICLOALQUILO, ALCOXI, ALQUILTIO (C1 (CH2)M X2)M ENDO H, ALQUILO, CICLOALQUILO (C -> C3); O R2 Y R3 FORMAN EN CONJUNTO SALES CON LAS BASES. LOS PRODUCTOS (I) PRESENTAN INTERESANTES PROPIEDADES ANTIINFLAMATORIAS.
ES94400009T 1993-01-05 1994-01-04 Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen. Expired - Lifetime ES2078130T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2078130T3 true ES2078130T3 (es) 1995-12-01

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400009T Expired - Lifetime ES2078130T3 (es) 1993-01-05 1994-01-04 Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen.

Country Status (33)

Country Link
US (1) US5346912A (es)
EP (1) EP0606175B1 (es)
JP (1) JP3334988B2 (es)
KR (1) KR100295717B1 (es)
CN (1) CN1042935C (es)
AT (1) ATE128968T1 (es)
AU (1) AU663017B2 (es)
BR (1) BR9400017A (es)
CA (1) CA2112866C (es)
CZ (1) CZ283948B6 (es)
DE (1) DE69400024T2 (es)
DK (1) DK0606175T3 (es)
EE (1) EE03001B1 (es)
ES (1) ES2078130T3 (es)
FI (1) FI106553B (es)
GB (1) GB9300083D0 (es)
GR (1) GR3017723T3 (es)
HR (1) HRP940006B1 (es)
HU (1) HU216835B (es)
IL (1) IL107788A (es)
LT (1) LT3766B (es)
LV (1) LV10712B (es)
MX (1) MX9400274A (es)
NO (1) NO300839B1 (es)
NZ (1) NZ250520A (es)
PL (1) PL175135B1 (es)
RU (1) RU2126387C1 (es)
SI (1) SI9300686A (es)
SK (1) SK280508B6 (es)
TW (1) TW259785B (es)
UA (1) UA40573C2 (es)
YU (1) YU49047B (es)
ZA (1) ZA939118B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338804A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
RU2516290C2 (ru) 2007-08-27 2014-05-20 Басф Се Пиразольные соединения и их использование в способе борьбы с беспозвоночными вредителями, в способе защиты материала размножения растений, в способе лечения или защиты животных от инвазии или инфицирования, в материале размножения растений и сельскохозяйственные композиции, содержащие пиразольные соединения
CA2736538C (en) 2008-09-24 2018-02-20 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2011003793A1 (en) 2009-07-06 2011-01-13 Basf Se Pyridazine compounds for controlling invertebrate pests
EP2451804B1 (en) 2009-07-06 2014-04-30 Basf Se Pyridazine compounds for controlling invertebrate pests
CN102469785A (zh) 2009-07-24 2012-05-23 巴斯夫欧洲公司 防治无脊椎动物害虫的吡啶衍生物
AU2014352920A1 (en) 2013-11-22 2016-06-23 Genzyme Corporation Novel methods for treating neurodegenerative diseases
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
US5494911A (en) * 1990-05-18 1996-02-27 Hoechst Aktiengesellschaft Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide

Also Published As

Publication number Publication date
NO940020D0 (no) 1994-01-04
ZA939118B (en) 1995-01-18
ATE128968T1 (de) 1995-10-15
AU663017B2 (en) 1995-09-21
SK280508B6 (sk) 2000-03-13
HU216835B (hu) 1999-09-28
FI940031A0 (fi) 1994-01-04
HU9400033D0 (en) 1994-05-30
YU82593A (sh) 1996-07-24
CZ292193A3 (en) 1994-07-13
HRP940006B1 (en) 1999-12-31
FI106553B (fi) 2001-02-28
JPH06211793A (ja) 1994-08-02
AU5213093A (en) 1994-07-14
DE69400024D1 (de) 1995-11-16
LV10712A (lv) 1995-06-20
EP0606175B1 (fr) 1995-10-11
TW259785B (en) 1995-10-11
LV10712B (en) 1995-12-20
NO940020L (es) 1994-07-06
HUT71471A (en) 1995-11-28
DE69400024T2 (de) 1996-04-04
IL107788A (en) 1998-08-16
EP0606175A1 (fr) 1994-07-13
CA2112866A1 (fr) 1994-07-06
RU2126387C1 (ru) 1999-02-20
BR9400017A (pt) 1994-08-02
PL175135B1 (pl) 1998-11-30
CN1042935C (zh) 1999-04-14
LT3766B (en) 1996-03-25
GB9300083D0 (en) 1993-03-03
RU94000064A (ru) 1996-07-10
CZ283948B6 (cs) 1998-07-15
GR3017723T3 (en) 1996-01-31
PL301774A1 (en) 1994-07-11
EE03001B1 (et) 1997-06-16
HRP940006A2 (en) 1996-10-31
US5346912A (en) 1994-09-13
MX9400274A (es) 1994-08-31
KR100295717B1 (ko) 2001-11-05
FI940031A (fi) 1994-07-06
UA40573C2 (uk) 2001-08-15
JP3334988B2 (ja) 2002-10-15
DK0606175T3 (da) 1996-02-19
SK149593A3 (en) 1994-12-07
CN1097005A (zh) 1995-01-04
IL107788A0 (en) 1994-02-27
NO300839B1 (no) 1997-08-04
CA2112866C (fr) 2007-03-13
LTIP1634A (en) 1995-02-27
NZ250520A (en) 1996-08-27
KR940018363A (ko) 1994-08-16
SI9300686A (en) 1994-09-30
YU49047B (sh) 2003-07-07

Similar Documents

Publication Publication Date Title
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
PT97890A (pt) Processo para a preparacao de ftalidas substituidas e de ftalidas heterociclicas
ITMI921203A1 (it) Derivati di s-triazina come agenti fotostabilizzanti
ES2176204T3 (es) Antidepresivos que contienen un derivado de xantina.
CO4130326A1 (es) Nuevos derivados de 2-ciano-1,3-diona, composiciones que los contienen, procedimientos para su preparacion y su uso como herbicidas
DK0778277T3 (da) Substituerede heterocycliske derivater som CRF antagonister
ES2119017T3 (es) Derivados que contienen azufre de 2-ciano-1,3-dionas y su uso como herbicidas.
MX9300222A (es) Nuevos derivados de arilcicloalquilo, su preparacion y su utilizacion.
ES2078130T3 (es) Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
FI955430A (fi) Bisyklisiä amidijohdannaisia ja niiden käyttö lihasten jännitystä laukaisevina aineena
PT99503A (pt) Processo para a preparacao de novos derivados da n-benzoil-prolina e de composicoes farmaceuticas que os contem
DK50086D0 (da) 3-phenyl-tetrahydropyridinderivater
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
DK415789D0 (da) Tetracykliske antidepressive midler
FI962587A (fi) 1,3-oksatsin-4-onijohdannaiset, menetelmä ja välituotteet niiden valmistamiseksi ja niiden käyttö herbisideinä
FI930367A0 (fi) Puridinderivat
PT90815A (pt) Processo de preparacao de derivados da fenotiazina
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
PT97255A (pt) Processo para a preparacao de 3-tia-alquil-flavonas e de 3-oxa-alquil flavonas e substituidas e de composicoes farmaceuticas que as contem
FI912828A0 (fi) N-oxi-imidsyraderivat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 606175

Country of ref document: ES